Goldman Sachs Call 600 MUV2 20.06.../ DE000GQ2MAM9 /
17/05/2024 10:43:13 | Chg.+0.090 | Bid22:00:44 | Demandez à22:00:44 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.810EUR | +12.50% | - Bid taille: - |
- Ask la taille: - |
MUENCH.RUECKVERS.VNA... | 600.00 EUR | 20/06/2025 | Call |
GlobeNewswire
23:39
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
23:15
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
23:03
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
23:00
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
23:00
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
22:48
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...
GlobeNewswire
22:42
MERGER INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Avangrid, Inc. (A...
GlobeNewswire
22:35
Breaking News: AthenaDexFi Launches Exciting Pre-Sale for ATH Token, Unveiling Lucrative Investment ...
GlobeNewswire
22:33
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
GlobeNewswire
22:30
Nuvini (Nasdaq: NVNI) Announces Nasdaq Notification of Non-Compliance Regarding Delayed Form 20-F Fi...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page